Bora Pharmaceuticals Featured in Fierce Pharma – Bora's Quest to Join Ranks of Top CDMOs - Bora Pharmaceuticals Premium CDMO
Por um escritor misterioso
Descrição
Fierce Pharma features a discussion with CEO, Bobby Sheng in an article entitled "After Bora's biologics debut, CEO outlines quest to join ranks of top CDMOs". Published on November 10, 2022Thank you Fierce Pharma and author Fraiser Kansteiner Bora's focus on customer partnership is key to Bora's acquisition strategy. Bora's recent addition of biologics offerings

Technology Transfer - Bora Pharmaceuticals Premium CDMO

Bora expands its CMDO capabilities as it makes landmark

Bora Pharmaceuticals Featured in Pharma Manufacturing – Three Fast

Mogene Contract Pharma

Bora Pharmaceuticals establishes biologics CDMO platform

Mogene Contract Pharma

Bora Pharmaceuticals acquires Eden Biologics CDMO Assets
Dosage Forms - Bora Pharmaceuticals Premium CDMO

Bora Pharmaceuticals collaborates with Taishin Holdings to launch

Mogene Contract Pharma
Bora Pharmaceuticals Featured in Fierce Pharma – Bora's Quest to

Member Companies Pharma & Biopharma Outsourcing Association
de
por adulto (o preço varia de acordo com o tamanho do grupo)